NO963559L - Rekombinante adenoviruser som koder for hjerne-avledet naurotrofisk faktor (BDNF) - Google Patents

Rekombinante adenoviruser som koder for hjerne-avledet naurotrofisk faktor (BDNF)

Info

Publication number
NO963559L
NO963559L NO963559A NO963559A NO963559L NO 963559 L NO963559 L NO 963559L NO 963559 A NO963559 A NO 963559A NO 963559 A NO963559 A NO 963559A NO 963559 L NO963559 L NO 963559L
Authority
NO
Norway
Prior art keywords
naurotrophic
bdnf
factor
derived
recombinant adenoviruses
Prior art date
Application number
NO963559A
Other languages
English (en)
Norwegian (no)
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO963559L publication Critical patent/NO963559L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO963559A 1994-03-18 1996-08-26 Rekombinante adenoviruser som koder for hjerne-avledet naurotrofisk faktor (BDNF) NO963559L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (fr) 1994-03-18 1994-03-18 Virus recombinants, préparation et utilisation en thérapie génique.
PCT/FR1995/000250 WO1995025804A1 (fr) 1994-03-18 1995-03-02 Adenovirus recombinants codant pour le facteur neurotrophique derive du cerveau (bdnf)

Publications (1)

Publication Number Publication Date
NO963559L true NO963559L (no) 1996-08-26

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963559A NO963559L (no) 1994-03-18 1996-08-26 Rekombinante adenoviruser som koder for hjerne-avledet naurotrofisk faktor (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (fr)
JP (1) JPH09510358A (fr)
KR (1) KR970701784A (fr)
AU (1) AU703793B2 (fr)
CA (1) CA2184200A1 (fr)
FI (1) FI963674A7 (fr)
FR (1) FR2717496B1 (fr)
IL (1) IL112992A0 (fr)
MX (1) MX9603490A (fr)
NO (1) NO963559L (fr)
WO (1) WO1995025804A1 (fr)
ZA (1) ZA952244B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
AU2001259453B2 (en) * 2000-05-05 2006-08-31 Beth Israel Deaconess Medical Center Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis
WO2019162942A1 (fr) * 2018-02-20 2019-08-29 Carmel Haifa University Economic Corporation Ltd. Compositions et procédés pour l'administration et l'expression de petits peptides inhibiteurs et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU94016525A (ru) * 1991-07-10 1996-06-10 Ридженерон Фармасьютикалз Способы лечения заболеваний двигательных нейронов
WO1993008828A1 (fr) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Traitements de lesions neuronales liees a l'ischemie, a l'hypoxie ou a la degenerescence neuronale
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
AU4995193A (en) * 1992-08-04 1994-03-03 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
ATE404683T1 (de) * 1992-09-25 2008-08-15 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2704234B1 (fr) * 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.

Also Published As

Publication number Publication date
KR970701784A (ko) 1997-04-12
FR2717496A1 (fr) 1995-09-22
JPH09510358A (ja) 1997-10-21
AU703793B2 (en) 1999-04-01
EP0750676A1 (fr) 1997-01-02
MX9603490A (es) 1997-03-29
ZA952244B (en) 1996-01-16
WO1995025804A1 (fr) 1995-09-28
AU1896295A (en) 1995-10-09
IL112992A0 (en) 1995-06-29
FI963674A0 (fi) 1996-09-17
FI963674L (fi) 1996-09-17
FI963674A7 (fi) 1996-09-17
FR2717496B1 (fr) 1996-04-12
CA2184200A1 (fr) 1995-09-28

Similar Documents

Publication Publication Date Title
IL116816A0 (en) Recombinant defective adenoviruses
FI935058A7 (fi) Kasvainten vastaiseen käsittelyyn tarkoitetut defektiiviset rekombinantti-adenovirukset, jotka ilmentävät sytokiineja
FI963805A7 (fi) Hermotukisoluista peräisin olevaa neurotrofista tekijää (GDNF) koodaav at yhdistelmä-DNA-tekniset adenovirukset
KR970700876A (ko) 영사기(projector)
DE69427370D1 (de) Neue integrinbindende peptide
DE69503375D1 (de) Hochauflösendes subtraktives farbprojektionssystem
FI965225L (fi) Uusia peptidejä
FI961350A7 (fi) Hapteenimerkityt peptidit
GB2291308B (en) Error diffusion image encoding
DE69718609D1 (de) Blockarchitektur mit Zeilenredundanz
FI954147L (fi) Polypeptidejä
NO976058L (no) Rekombinant mistellectin
DE69736966D1 (de) LCD-Farbprojektor
FI953302A7 (fi) Uudet peptidit
ATE480626T1 (de) Neue streptogramine
GB2338082B (en) Projector transporter
FI971499A7 (fi) Uusia peptidejä joilla on immunomodulatorisia vaikutuksia
DE69310280D1 (de) Aluminiumoxid-, Calciumoxid-, Yttriumoxid-Dichtungsmittel-Zusammensetzung
FI970168A0 (fi) Peptidejä
FI933495L (fi) Rekombinantadenovirusvacciner
FI964363L (fi) Peptidejä
FI943626L (fi) Rekombinanttiadenovirusrokotteita
NO963559L (no) Rekombinante adenoviruser som koder for hjerne-avledet naurotrofisk faktor (BDNF)
DE69622119D1 (de) Farbprojektor
FI953451A7 (fi) Karbonointiin liittyvät parannukset

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application